The Clinical Application of 68Ga Labeled ssDNA Aptamer Sgc8 in Healthy Volunteers and Colorectal Patients
Status:
Unknown status
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
The protein tyrosine kinase-7 (PTK7) is overexpressed in various types of human cancers. As a
specific imaging agent of PTK7, 68Ga-Sgc8 was investigated in this study to assess its
safety, biodistribution and dosimetric properties in healthy volunteers, and to preliminarily
evaluate its application in colorectal patients.